Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.

Year-over-year quarterly sales growth most ... change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%. Looking at the Momentum Grade breakdown above, both ...

Currently, Hims & Hers Health, Inc.’s price-earnings ratio is 70.3. Hims & Hers Health, Inc.’s trailing 12-month revenue is $1.5 billion with a 8.5% net profit margin. Year-over-year quarterly sales ...

Several studies have been done on the myriad list of side effects that come from popular weight loss drugs.  A new study ...

Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.

Hims & Hers Health (NYSE:HIMS) has taken investors on a wild ride in 2025. The stock surged nearly 200% earlier this year, reaching an ...

Researchers assessed data from 16 million patients from 2006 to 2020 taking semaglutide-based drugs; the active ingredient in Wegovy.

Losing weight can improve your health and self-esteem. But shedding excess pounds can also lead to a less desirable side effect — hair loss! Registered dietitian nutritionist Kait Richardson ...

Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering compounded ...

Along with these facial benefits, some believe using a dermaroller on your scalp could help encourage hair growth. There’s an entire contingency of people on TikTok who swear it has worked for them.

For some people, Lexapro can cause weight loss, while for others, it may cause an increase in food intake and weight gain. Below, we’ve covered what Lexapro is, as well as why your mental health ...